echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Biogynocinagen Sodium was included in the new medical insurance drug list, and it was successfully implemented on the first day of landing

    Biogynocinagen Sodium was included in the new medical insurance drug list, and it was successfully implemented on the first day of landing

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>


    As the world's first SMA disease modification treatment drug, Noxinagen Sodium was "insured" for the first time and received widespread attention from the society


    China speeds up the last mile of medical insurance medication in one month

    With the continuous deepening of medical insurance reform, the time for the implementation of medical insurance policies has also been shortened year by year


    High-value rare disease drugs are included in the medical insurance drug list for the first time , demonstrating that the Chinese government attaches great importance to drug protection for patients with rare diseases


    The low accessibility of rare disease drugs enrolled in the insurance "break-through" helps improve the level of diagnosis and treatment of SMA

    As the doctor who prescribed the first batch of prescriptions for Nocinnasheng Sodium Injection after entering the medical insurance catalogue, Professor Zhong Jianmin, Department of Neurology , Jiangxi Children’s Hospital, said : “SMA is currently the number one genetic disease killer for infants under two years old.


    Noxinagen sodium is an antisense oligonucleotide drug that accurately targets the cause of SMA, effectively improves patient's vital functions such as exercise and breathing, improves survival rate, and changes the disease process of SMA


    All parties work together to provide the best New Year gifts for SMA patients

    On New Year's Day, medical staff in various medical institutions gave up the holiday break and worked overtime to treat SMA patients


    Xing Huanping, executive director of the patient organization Meier SMA Care Center, said: " As a member of the SMA Patient Care Center, we have witnessed that the patient group has gone from no medicine to hope of treatment, and now enjoys the medical insurance policy, and the family burden is greatly reduced


    This month, the medical insurance policy of Nosina Sodium will be successively implemented in more than 20 provinces and cities across the country.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.